Measuring the impact of the updated Steatotic liver disease nomenclature and definition

Liver Int. 2023 Nov;43(11):2340-2342. doi: 10.1111/liv.15731.

Luca Valenti^{1

2}, Alessio Aghemo^{3

4}, Alejandro Forner^{5

6}, Salvatore Petta⁷, Stefano Romeo^{8

9

10}, Pierre Nahon^{11

12

13}

¹ Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
² Precision Medicine, Biological Resource Center and Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
³ Division of Internal Medicine and Hepatology, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Milan, Italy.
⁴ Department of Biomedical Sciences, Humanitas University, Milan, Italy.
⁵ Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, ICMDM, Hospital Clinic Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.
⁶ Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.
⁷ Sezione di Gastroenterologia e Epatologia, Dipartimento di Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza "G. D'Alessandro", University of Palermo, Palermo, Italy.
⁸ Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
⁹ Cardiology Department, Sahlgrenska University Hospital, Gothenburg, Sweden.
¹⁰ Clinical Nutrition Unit, Department of Medical and Surgical Sciences, University Magna Graecia, Catanzaro, Italy.
¹¹ APHP, Liver Unit, Bobigny, France.
¹² Université Sorbonne Paris Nord, F-93000, Bobigny, France.
¹³ Inserm, UMR-1138 "Functional Genomics of Solid Tumors", Centre de Recherche des Cordeliers, Université de Paris, Paris, France.

No abstract available

Publication types